Follow us on Twitter

Tuesday 5 August 2014

Medivir licenses Respiratory Syncytial Virus drug program from Boehringer Ingelheim - WSJ.com

http://online.wsj.com/article/PR-CO-20140804-901143.html

Posted by Rob LW

No comments:

Post a Comment